{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:16:54Z","timestamp":1788419814558,"version":"build-2803163510"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Impulse control disorders (ICDs) are clinically relevant non-motor complications of Parkinson\u2019s disease (PD). ICDs include gambling, hypersexuality, compulsive shopping, binge eating, hobbyism\/punding, and dopamine dysregulation syndrome. Although dopaminergic replacement therapies are a key risk factor, only a subgroup of treated patients develop ICDs, potentially suggesting that neuropsychological differences may contribute to interindividual variability. Dysfunctional Metacognitive Beliefs (MBs) have recently been associated with addictive behaviors in the general population, but their role in neurologically driven addictive-like behaviors has not yet been examined. This exploratory study aimed to investigate whether dysfunctional MBs are associated with ICD symptom severity in PD patients after controlling for variables of dopaminergic exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>38 PD patients (44.7% F, mean age 67.55) completed the Metacognitions Questionnaire-30 (MCQ-30) and the Questionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease-Rating Scale (QUIP-RS). One-sample t-tests were used to compare MCQ scores with normative values from the Italian general community sample. Two-tailed partial correlations tested associations between MCQ-30 scores and QUIP-RS outcomes, controlling for treatment duration, dopamine agonist exposure (LEDD-DA), and other dopaminergic exposures (i.e., total LEDD minus LEDD-DA). Additionally, independent samples t-tests were conducted to compare MCQ-30 scores between patients with and without ICDs. False discovery rate correction was applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 23.7% of patients exceeded the QUIP-ICD cut-off. Compared with normative data from the general community sample, PD patients showed a more dysfunctional metacognitive profile. After controlling for dopaminergic exposure, ICD symptom severity was associated with positive beliefs about worry, negative beliefs about uncontrollability and danger, reduced cognitive confidence, greater need to control thoughts, and lower cognitive self-consciousness. In group comparisons, patients exceeding the QUIP-ICD cut-off showed significantly higher MCQ-POS, MCQ-NEG, and MCQ-NC scores and lower MCQ-CSC scores than those below the cut-off.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These exploratory findings suggest that, after controlling for dopaminergic variables, dysfunctional MBs are associated with ICD symptom severity. In this context, MBs may represent one of the cognitive-affective correlates of ICD interindividual variability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1893510","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:44:50Z","timestamp":1788417890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of metacognitive beliefs in impulse control disorders and addictive-like behaviors in Parkinson\u2019s disease: an exploratory study"],"prefix":"10.3389","volume":"17","author":[{"given":"Sergio","family":"Triscari","sequence":"first","affiliation":[{"name":"Department of Educational Sciences, Section of Psychology, University of Catania","place":["Catania, Italy"]},{"name":"Neuropharmacology and Translational Neuroscience Unit, Oasi Research Institute \u2013 I.R.C.C.S","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Lenzo","sequence":"additional","affiliation":[{"name":"Department of Educational Sciences, Section of Psychology, University of Catania","place":["Catania, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Sardella","sequence":"additional","affiliation":[{"name":"Department of Educational Sciences, Section of Psychology, University of Catania","place":["Catania, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Caponnetto","sequence":"additional","affiliation":[{"name":"Department of Educational Sciences, Section of Psychology, University of Catania","place":["Catania, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Galati","sequence":"additional","affiliation":[{"name":"Rehabilitation Psychology Unit, Department of Rehabilitation, Oasi Research Institute \u2013 I.R.C.C.S","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lupica","sequence":"additional","affiliation":[{"name":"Rehabilitation Psychology Unit, Department of Rehabilitation, Oasi Research Institute \u2013 I.R.C.C.S","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Tasca","sequence":"additional","affiliation":[{"name":"Rehabilitation Psychology Unit, Department of Rehabilitation, Oasi Research Institute \u2013 I.R.C.C.S","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Muratore","sequence":"additional","affiliation":[{"name":"Rehabilitation Psychology Unit, Department of Rehabilitation, Oasi Research Institute \u2013 I.R.C.C.S","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Marano","sequence":"additional","affiliation":[{"name":"Neurorehabilitation Unit, Department of Rehabilitation, Oasi Research Institute \u2013 I.R.C.C.S","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Caraci","sequence":"additional","affiliation":[{"name":"Neuropharmacology and Translational Neuroscience Unit, Oasi Research Institute \u2013 I.R.C.C.S","place":["Troina, Italy"]},{"name":"Department of Drug and Health Sciences, University of Catania","place":["Catania, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Quattropani","sequence":"additional","affiliation":[{"name":"Department of Educational Sciences, Section of Psychology, University of Catania","place":["Catania, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s disease and parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(09)70847-8","article-title":"Impulse control disorders in Parkinson\u2019s disease: definition, epidemiology, risk factors, neurobiology and management","volume":"15","author":"Ceravolo","year":"2009","journal-title":"Parkinsonism Related Disord"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.635494","article-title":"Impulse control disorders in Parkinson\u2019s disease: Epidemiology, pathogenesis and therapeutic strategies","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03218.x","article-title":"Impulse control disorders in patients with Parkinson\u2019s disease receiving dopamine replacement therapy: evidence and implications for the addictions field","volume":"106","author":"Ambermoon","year":"2011","journal-title":"Addiction"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00654","article-title":"Impulse control disorder in parkinson\u2019s disease: A meta-analysis of cognitive, affective, and motivational correlates","volume":"9","author":"Martini","year":"2018","journal-title":"Front Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311827","article-title":"Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease","volume":"87","author":"Smith","year":"2016","journal-title":"J Neurology Neurosurg Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000202","article-title":"A multicenter comparative study of impulse control disorder in latin american patients with parkinson disease","volume":"40","author":"Ram\u00edrez G\u00f3mez","year":"2017","journal-title":"Clin Neuropharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29700","article-title":"Management of impulse control and related disorders in parkinson\u2019s disease: an expert consensus","volume":"39","author":"Debove","year":"2024","journal-title":"Movement Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23501","article-title":"Impulsivity and compulsivity in drug\u2010na\u00efve patients with Parkinson\u2019s disease","volume":"26","author":"Antonini","year":"2011","journal-title":"Movement Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12646","article-title":"Impulse control disorders in Parkinson\u2019s disease: don\u2019t set your mind at rest by self\u2010assessments","volume":"22","author":"Baumann-Vogel","year":"2015","journal-title":"Eur J Neurol"},{"key":"B13","first-page":"65","article-title":"Metacognition, executive control, self-regulation, and other more mysterious mechanisms","volume-title":"Metacognition, Motivation, and Understanding","author":"Brown","year":"1987"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2014.00443","article-title":"How to measure metacognition","volume":"8","author":"Fleming","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"B15","volume-title":"Metacognitive Therapy for Anxiety and Depression","author":"Wells","year":"2009"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7967(03)00147-5","article-title":"A short form of the metacognitions questionnaire: Properties of the MCQ-30","volume":"42","author":"Wells","year":"2004","journal-title":"Behav Res Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7967(96)00050-2","article-title":"Modelling cognition in emotional disorder: The S-REF model","volume":"34","author":"Wells","year":"1996","journal-title":"Behav Res Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2019.02621","article-title":"Breaking the cybernetic code: Understanding and treating the human metacognitive control system to enhance mental health","volume":"10","author":"Wells","year":"2019","journal-title":"Front Psychol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2017.05.029","article-title":"Dysfunctional metacognition across psychopathologies: A meta-analytic review","volume":"45","author":"Sun","year":"2017","journal-title":"Eur Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.addbeh.2014.08.002","article-title":"Metacognition in addictive behaviors","volume":"44","author":"Spada","year":"2015","journal-title":"Addict Behav"},{"key":"B21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.addbeh.2018.05.018","article-title":"Metacognitive beliefs in addictive behaviours: A systematic review","volume":"85","author":"Hamonniere","year":"2018","journal-title":"Addict Behav"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13566","article-title":"Movement disorder society unified parkinson\u2019s disease rating scale motor examination retains its 2\u2010Domain profile in both on and off states","volume":"9","author":"Guo","year":"2022","journal-title":"Movement Disord Clin Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"B24","article-title":"Montreal cognitive assessment (MoCA)","volume-title":"APA Psyctests","author":"Nasreddine","year":"2005"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1027\/1015-5759\/a000217","article-title":"Italian validation of montreal cognitive assessment","volume":"31","author":"Pirrotta","year":"2015","journal-title":"Eur J psychol Assess"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-005-0443-4","article-title":"The Frontal Assessment Battery (FAB): normative values in an Italian population sample","volume":"26","author":"Appollonio","year":"2005","journal-title":"Neurological Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20154","article-title":"DSM-5 cross-cutting symptom measures: a step towards the future of psychiatric care","volume":"13","author":"Clarke","year":"2014","journal-title":"World Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Movement Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29410","article-title":"Levodopa dose equivalency in parkinson\u2019s disease: updated systematic review and proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Movement Disord"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for impulsive\u2010compulsive disorders in Parkinson\u2019s Disease\u2013Rating Scale","volume":"27","author":"Weintraub","year":"2012","journal-title":"Movement Disord"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07304-2","article-title":"Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease-Rating Scale (QUIP-RS) in an Italian Parkinson\u2019s disease cohort","volume":"45","author":"Maggi","year":"2024","journal-title":"Neurological Sci"},{"key":"B32","first-page":"29","article-title":"Psychometric properties of the Italian version of the Short Form of the Metacognitions Questionnaire (MCQ-30)","volume":"62","author":"Quattropani","year":"2014","journal-title":"Bollettino di Psicologia Applicata"},{"key":"B33","article-title":"Metacognitions questionnaire\u2013short form (Italian version, MCQ-30)","volume-title":"APA Psyctests","author":"Quattropani","year":"2014"},{"key":"B34","unstructured":"Ibm Spss Statistics (Version 32.0)\n          \n          2026"},{"key":"B35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Method"},{"key":"B36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/978-1-4419-9863-7_1215","article-title":"Benjamini\u2013hochberg method","volume-title":"Encyclopedia of Systems Biology","author":"Haynes","year":"2013"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, moCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatrics Soc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.2.182","article-title":"Distress in Parkinson's disease: contributions of disease factors and metacognitive style","volume":"187","author":"Allott","year":"2005","journal-title":"Br J Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2015.05.001","article-title":"Thinking about motor fluctuations: An examination of metacognitions in Parkinson's disease","volume":"79","author":"Fernie","year":"2015","journal-title":"J Psychosomatic Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jpsychores.2017.11.014","article-title":"The clinical utility of metacognitive beliefs and processes in emotional distress in people with multiple sclerosis","volume":"104","author":"Heffer-Rahn","year":"2018","journal-title":"J Psychosomatic Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yebeh.2018.07.008","article-title":"Metacognitive beliefs and illness perceptions are associated with emotional distress in people with epilepsy","volume":"86","author":"Fisher","year":"2018","journal-title":"Epilepsy Behav"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.609068","article-title":"The association between maladaptive metacognitive beliefs and emotional distress in people living with amyotrophic lateral sclerosis","volume":"12","author":"Dodd","year":"2021","journal-title":"Front Psychol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1177\/0891988716640374","article-title":"Association between metacognition and mood symptoms poststroke","volume":"29","author":"Donnellan","year":"2016","journal-title":"J Geriatric Psychiatry Neurol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305896","article-title":"Metacognitive beliefs, mood symptoms, and fatigue four years after stroke: An explorative study","volume":"19","author":"Pedersen","year":"2024","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2026.108613","article-title":"Metacognitive beliefs and addictions: A systematic review and meta-analysis with emphasis on the mediating role of desire thinking","volume":"175","author":"Akbari","year":"2026","journal-title":"Addict Behav"},{"key":"B47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cbpra.2021.11.002","article-title":"A brief history of metacognitive therapy: From cognitive science to clinical practice","volume":"30","author":"Capobianco","year":"2023","journal-title":"Cogn Behav Pract"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00351","article-title":"Impulse control disorders in Parkinson's disease. A brief and comprehensive review","volume":"10","author":"Gatto","year":"2019","journal-title":"Front Neurol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.06.025","article-title":"Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [11C]-PHNO PET study","volume":"90","author":"Pagano","year":"2021","journal-title":"Parkinsonism Related Disord"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp054","article-title":"Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study","volume":"132","author":"Steeves","year":"2009","journal-title":"Brain"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr003","article-title":"Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours","volume":"134","author":"O\u2019Sullivan","year":"2011","journal-title":"Brain"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001619","article-title":"Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease","volume":"84","author":"Carriere","year":"2015","journal-title":"Neurology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27139","article-title":"Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease","volume":"32","author":"Tessitore","year":"2017","journal-title":"Movement Disord"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa198","article-title":"Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder","volume":"143","author":"Drew","year":"2020","journal-title":"Brain"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad162","article-title":"Impulse control disorder in Parkinson's disease is associated with abnormal frontal value signalling","volume":"146","author":"Tichelaar","year":"2023","journal-title":"Brain"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1893510\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:44:52Z","timestamp":1788417892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1893510\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":55,"alternative-id":["10.3389\/fpsyt.2026.1893510"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1893510","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1893510"}}